Market Overview:
The global epinephrine market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of anaphylaxis, rising number of cardiac arrests, and growing demand for combination epinephrine products. However, the high cost of epinephrine products is expected to restrain the growth of this market during the forecast period. The global epinephrine market is segmented by type, application, and region. By type, the market is divided into Epinephrine Auto-injector (EAI), Epinephrine Prefilled Syringe (EPS), and Combination Epinephrine Products (CEP). EAI held a dominant position in 2017 and is projected to maintain its dominance during the forecast period owing to its ease-of-use and increased adoption among patients suffering from anaphylaxis. EPS are anticipated to witness significant growth during the forecast period due their low cost as compared with EAIs and CEPs. By application,the global epinephrinemarketis segmented into Anaphylaxis,, Cardiac Arrest,,and Others,. Anaphylaxis accounted for majority share in 2017 owingtoits high prevalence across all regions studied in this research study..
Product Definition:
Epinephrine is a hormone and neurotransmitter that is responsible for the "fight or flight" response. It increases heart rate, blood pressure, and breathing rate, and it also opens up airways in the lungs. Epinephrine is important for responding to emergencies because it helps prepare the body to deal with a stressful situation.
Epinephrine Auto-injector:
Epinephrine (Adrenaline) auto-injector is a device that enables the user to deliver an injection of epinephrine (adrenaline) on impulse. The Epinephrine Auto-Injector market is driven by factors such as increasing awareness among consumers regarding self-care, growing prevalence of life threatening allergic conditions and rising number of accidental injuries.
U.S Epinephrine Auto Injector Market, by Product Type 2014 - 2022 -> The U.
Epinephrine Prefilled Syringe:
Epinephrine (Adrenaline) is a colorless clear sterile solution used in the treatment of anaphylaxis which occurs due to rapid heart rate, weak pulse, and breathlessness. It works by opening airways, increasing blood flow to the lungs and accelerating the heart rate.
Application Insights:
Anaphylaxis was the leading application segment in terms of revenue share in 2017. Anaphylaxis is a severe allergic reaction that can lead to death within minutes without treatment. The incidence of anaphylaxis has increased significantly over the past few years and a high number of deaths are reported due to this condition every year. Epinephrine is widely used for the treatment of anaphylaxis as it works quickly than other treatments such as oxygen and antihistamines.
The cardiac arrest segment is expected to grow at fastest rate during forecast period owing to increasing cases of sudden cardiac arrest among children and adults across the globe, especially in developing countries like India, China etc., where most fatal heart attacks occur outside hospitals due to lack of proper healthcare facilities at home; these factors are likely drive market growth during forecast period (2018-2030).
Regional Analysis:
Europe dominated the global epinephrine market in 2017 owing to a rise in awareness about anaphylaxis and increasing incidence of food allergies. In addition, presence of regulatory bodies for the approval of products is also expected to drive regional growth. For instance, EMA has approved Mylan's EpiPen for marketing across Europe since it met the required standards.
Asia Pacific is expected to grow at a lucrative rate over the forecast period due to factors such as growing economy and improving healthcare infrastructure that leads to increased adoption of these auto-injectors & prefilled syringes among patients suffering from life-threatening allergic reactions & anaphylaxis.
Growth Factors:
- Increasing incidence of anaphylaxis: The increasing incidence of anaphylaxis is one of the key growth drivers for the epinephrine market. Anaphylaxis is a serious, potentially life-threatening allergic reaction that can occur within minutes after exposure to an allergen. According to a study by Allergy UK, around 1 in 50 people in the UK suffer from anaphylaxis every year and this number is on the rise. This growing prevalence of allergies is expected to drive demand for epinephrine products in the coming years.
- Growing awareness about self-injectable epinephrine devices: There has been a growing awareness among patients about self-injectable epinephrine devices in recent years. This has led to an increase in adoption rates of these devices, which is expected to drive market growth over the forecast period.
- Rising prevalence of food allergies: The rising prevalence of food allergies across all age groups is another major factor driving market growth globally. According to a study by FAIR Health, Inc., food allergies account for nearly half (47%)of all reported cases involving adverse reactions resulting from ingestion or contact with foods during 2016–2017 period studied). This high incidence rate is expected to create significant demand for epinephrine products in coming years . 4) Technological advancements: The advent of novel technologies such as smart auto-injectors and wearable patches are likely to fuel market growth over the forecast
Scope Of The Report
Report Attributes
Report Details
Report Title
Epinephrine Market Research Report
By Type
Epinephrine Auto-injector, Epinephrine Prefilled Syringe, Combination Epinephrine Products
By Application
Anaphylaxis, Cardiac Arrest, Others
By Companies
Mylan Inc, Impax, ALK Abello, Lincoln Medical Ltd, Pfizer, Amphastar, Emerade, Grand Pharma, Harvest Pharmaceuticals, Merit Pharmaceutical, Tianjin Jinyao Group
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
245
Number of Tables & Figures
172
Customization Available
Yes, the report can be customized as per your need.
Global Epinephrine Market Report Segments:
The global Epinephrine market is segmented on the basis of:
Types
Epinephrine Auto-injector, Epinephrine Prefilled Syringe, Combination Epinephrine Products
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Anaphylaxis, Cardiac Arrest, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Mylan Inc
- Impax
- ALK Abello
- Lincoln Medical Ltd
- Pfizer
- Amphastar
- Emerade
- Grand Pharma
- Harvest Pharmaceuticals
- Merit Pharmaceutical
- Tianjin Jinyao Group
Highlights of The Epinephrine Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Epinephrine Auto-injector
- Epinephrine Prefilled Syringe
- Combination Epinephrine Products
- By Application:
- Anaphylaxis
- Cardiac Arrest
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Epinephrine Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Epinephrine is a hormone that helps the body respond to emergencies by increasing heart rate, blood flow and respiration. It is also used to treat anaphylaxis, a life-threatening allergic reaction.
Some of the key players operating in the epinephrine market are Mylan Inc, Impax, ALK Abello, Lincoln Medical Ltd, Pfizer, Amphastar, Emerade, Grand Pharma, Harvest Pharmaceuticals, Merit Pharmaceutical, Tianjin Jinyao Group.
The epinephrine market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Epinephrine Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Epinephrine Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Epinephrine Market - Supply Chain
4.5. Global Epinephrine Market Forecast
4.5.1. Epinephrine Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Epinephrine Market Size (000 Units) and Y-o-Y Growth
4.5.3. Epinephrine Market Absolute $ Opportunity
5. Global Epinephrine Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Epinephrine Market Size and Volume Forecast by Type
5.3.1. Epinephrine Auto-injector
5.3.2. Epinephrine Prefilled Syringe
5.3.3. Combination Epinephrine Products
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Epinephrine Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Epinephrine Market Size and Volume Forecast by Application
6.3.1. Anaphylaxis
6.3.2. Cardiac Arrest
6.3.3. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Epinephrine Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Epinephrine Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Epinephrine Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Epinephrine Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Epinephrine Demand Share Forecast, 2019-2029
9. North America Epinephrine Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Epinephrine Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Epinephrine Market Size and Volume Forecast by Application
9.4.1. Anaphylaxis
9.4.2. Cardiac Arrest
9.4.3. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Epinephrine Market Size and Volume Forecast by Type
9.7.1. Epinephrine Auto-injector
9.7.2. Epinephrine Prefilled Syringe
9.7.3. Combination Epinephrine Products
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Epinephrine Demand Share Forecast, 2019-2029
10. Latin America Epinephrine Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Epinephrine Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Epinephrine Market Size and Volume Forecast by Application
10.4.1. Anaphylaxis
10.4.2. Cardiac Arrest
10.4.3. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Epinephrine Market Size and Volume Forecast by Type
10.7.1. Epinephrine Auto-injector
10.7.2. Epinephrine Prefilled Syringe
10.7.3. Combination Epinephrine Products
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Epinephrine Demand Share Forecast, 2019-2029
11. Europe Epinephrine Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Epinephrine Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Epinephrine Market Size and Volume Forecast by Application
11.4.1. Anaphylaxis
11.4.2. Cardiac Arrest
11.4.3. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Epinephrine Market Size and Volume Forecast by Type
11.7.1. Epinephrine Auto-injector
11.7.2. Epinephrine Prefilled Syringe
11.7.3. Combination Epinephrine Products
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Epinephrine Demand Share, 2019-2029
12. Asia Pacific Epinephrine Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Epinephrine Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Epinephrine Market Size and Volume Forecast by Application
12.4.1. Anaphylaxis
12.4.2. Cardiac Arrest
12.4.3. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Epinephrine Market Size and Volume Forecast by Type
12.7.1. Epinephrine Auto-injector
12.7.2. Epinephrine Prefilled Syringe
12.7.3. Combination Epinephrine Products
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Epinephrine Demand Share, 2019-2029
13. Middle East & Africa Epinephrine Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Epinephrine Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Epinephrine Market Size and Volume Forecast by Application
13.4.1. Anaphylaxis
13.4.2. Cardiac Arrest
13.4.3. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Epinephrine Market Size and Volume Forecast by Type
13.7.1. Epinephrine Auto-injector
13.7.2. Epinephrine Prefilled Syringe
13.7.3. Combination Epinephrine Products
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Epinephrine Demand Share, 2019-2029
14. Competition Landscape
14.1. Global Epinephrine Market: Market Share Analysis
14.2. Epinephrine Distributors and Customers
14.3. Epinephrine Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Mylan Inc
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Impax
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. ALK Abello
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Lincoln Medical Ltd
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Pfizer
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Amphastar
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Emerade
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Grand Pharma
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Harvest Pharmaceuticals
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Merit Pharmaceutical
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Tianjin Jinyao Group
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
